The international liquid biopsy analysis sector is seeing significant growth, driven by progress in oncology diagnosis and targeted healthcare. Current estimates position the market revenue at roughly USD X billion in the current year, with expectations pointing to a a anticipated CAGR of Y.Z percent through 2033. Dominant trends encompass the i… Read More